Andreas A. Argyriou

13.3k total citations · 2 hit papers
189 papers, 7.3k citations indexed

About

Andreas A. Argyriou is a scholar working on Oncology, Neurology and Psychiatry and Mental health. According to data from OpenAlex, Andreas A. Argyriou has authored 189 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Oncology, 40 papers in Neurology and 36 papers in Psychiatry and Mental health. Recurrent topics in Andreas A. Argyriou's work include Cancer Treatment and Pharmacology (63 papers), Multiple Myeloma Research and Treatments (31 papers) and Glioma Diagnosis and Treatment (25 papers). Andreas A. Argyriou is often cited by papers focused on Cancer Treatment and Pharmacology (63 papers), Multiple Myeloma Research and Treatments (31 papers) and Glioma Diagnosis and Treatment (25 papers). Andreas A. Argyriou collaborates with scholars based in Greece, Italy and Spain. Andreas A. Argyriou's co-authors include Haralabos P. Kalofonos, Massimiliano Pontil, Theodoros Evgeniou, Gregoris Iconomou, Jordi Bruna, Guido Cavaletti, Elisabeth Chroni, Panagiotis Polychronopoulos, Spiridon Papapetropoulos and Paola Alberti and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Neurology.

In The Last Decade

Andreas A. Argyriou

180 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Convex multi-task feature learning

2008 895 citations Andreas A. Argyriou, Massimiliano Pontil et al. profile →
Chemotherapy-induced peripheral neurotoxicity (CIPN): An update

2011 431 citations Andreas A. Argyriou, Jordi Bruna et al. Critical Reviews in Oncology/Hematology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas A. Argyriou Greece	45	3.2k	1.2k	1.1k	981	968	189	7.3k
Arun V. Krishnan Australia	45	1.7k 0.5×	535 0.5×	651 0.6×	1.4k 1.4×	1.9k 1.9×	228	7.0k
Bin Zhang China	52	2.1k 0.7×	214 0.2×	157 0.1×	1.9k 1.9×	506 0.5×	673	11.8k
Martin Dugas Germany	52	611 0.2×	2.3k 1.9×	445 0.4×	4.6k 4.7×	189 0.2×	347	9.9k
Judith Manola United States	55	4.8k 1.5×	326 0.3×	141 0.1×	4.9k 5.0×	203 0.2×	189	14.2k
Tatsuhiko Tsunoda Japan	74	2.5k 0.8×	307 0.3×	223 0.2×	9.6k 9.7×	160 0.2×	277	17.6k
Ulrich Mansmann Germany	59	3.0k 0.9×	450 0.4×	82 0.1×	2.3k 2.3×	1.4k 1.4×	362	11.4k
Mignon L. Loh United States	57	3.1k 1.0×	5.5k 4.7×	90 0.1×	10.1k 10.3×	545 0.6×	317	19.7k
Hans A. Kestler Germany	45	917 0.3×	416 0.4×	57 0.1×	3.4k 3.5×	127 0.1×	264	7.2k
Eric Bair United States	40	507 0.2×	454 0.4×	49 0.0×	2.2k 2.2×	1.3k 1.3×	92	8.0k
Miguel Martín Spain	68	12.4k 3.8×	247 0.2×	433 0.4×	3.8k 3.9×	92 0.1×	519	18.7k

Countries citing papers authored by Andreas A. Argyriou

Since Specialization

Citations

This map shows the geographic impact of Andreas A. Argyriou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas A. Argyriou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas A. Argyriou more than expected).

Fields of papers citing papers by Andreas A. Argyriou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas A. Argyriou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas A. Argyriou. The network helps show where Andreas A. Argyriou may publish in the future.

Co-authorship network of co-authors of Andreas A. Argyriou

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas A. Argyriou. A scholar is included among the top collaborators of Andreas A. Argyriou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas A. Argyriou. Andreas A. Argyriou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Alberti, Paola, Andreas A. Argyriou, Jordi Bruna, et al.. (2024). Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)—a white paper. Supportive Care in Cancer. 32(2). 117–117. 2 indexed citations

Velasco, Roser, Andreas A. Argyriou, David R. Cornblath, et al.. (2024). Repurposing chemotherapy‐induced peripheral neuropathy grading. European Journal of Neurology. 31(12). e16457–e16457. 4 indexed citations

Park, Susanna B., et al.. (2023). Axonal degeneration in chemotherapy-induced peripheral neurotoxicity: clinical and experimental evidence. Journal of Neurology Neurosurgery & Psychiatry. 94(11). 962–972. 34 indexed citations

Vikelis, Michail, et al.. (2023). A Survey of Greek Primary Care Physicians on Their Likeability in Treating Migraines and Other Common Diseases. Medicina. 59(4). 734–734.

Xiromerisiou, Georgia, et al.. (2023). Single OnabotulinumtoxinA Session Add-On to Carbamazepine or Oxcarbazepine in Treatment-Refractory Trigeminal Neuralgia: A Case Series with 24-Week Follow Up. Toxins. 15(9). 539–539. 1 indexed citations

Bruna, Jordi, Andreas A. Argyriou, Sara Mariotto, et al.. (2022). Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel‐induced peripheral neurotoxicity in breast cancer patients. Journal of the Peripheral Nervous System. 27(2). 166–174. 31 indexed citations

Cai, Jinhua, Junjiong Zheng, Jun Shen, et al.. (2020). A Radiomics Model for Predicting the Response to Bevacizumab in Brain Necrosis after Radiotherapy. Clinical Cancer Research. 26(20). 5438–5447. 38 indexed citations

Argyriou, Andreas A., et al.. (2020). Real world, open label experience with lacosamide against acute painful oxaliplatin‐induced peripheral neurotoxicity. Journal of the Peripheral Nervous System. 25(2). 178–183. 8 indexed citations

Velasco, Roser, Paola Alberti, Jordi Bruna, Dimitri Psimaras, & Andreas A. Argyriou. (2019). Bortezomib and other proteosome inhibitors—induced peripheral neurotoxicity: From pathogenesis to treatment. Journal of the Peripheral Nervous System. 24(S2). S52–S62. 47 indexed citations

10.

Lustberg, Maryam B., et al.. (2019). Vinca alkaloids, thalidomide and eribulin‐induced peripheral neurotoxicity: From pathogenesis to treatment. Journal of the Peripheral Nervous System. 24(S2). S63–S73. 44 indexed citations

11.

Dimitropoulou, Dimitra, et al.. (2018). Fatal, paraparetic acute motor axonal neuropathy, early complicating chemotherapy with nab-paclitaxel. Anti-Cancer Drugs. 30(4). 422–424. 2 indexed citations

12.

Suykens, Johan A. K., Andreas A. Argyriou, Kris De Brabanter, et al.. (2013). International workshop on advances in regularization, optimization, kernel methods and support vector machines : theory and applications (ROKS 2013). Lirias (KU Leuven). 1–128. 1 indexed citations

13.

Baldassarre, Luca, et al.. (2012). A General Framework for Structured Sparsity via Proximal Optimization. UCL Discovery (University College London). 82–90. 7 indexed citations

14.

Argyriou, Andreas A., Jordi Bruna, P Marmiroli, & Guido Cavaletti. (2011). Chemotherapy-induced peripheral neurotoxicity (CIPN): An update. Critical Reviews in Oncology/Hematology. 82(1). 51–77. 431 indexed citations breakdown →

15.

Argyriou, Andreas A., Charles A. Micchelli, Massimiliano Pontil, Lixin Shen, & Yuesheng Xu. (2011). Efficient First Order Methods for Linear Composite Regularizers. Syracuse University Libraries (Syracuse University). 5 indexed citations

16.

Argyriou, Andreas A., et al.. (2010). F-Wave Characteristics as Surrogate Markers of Spasticity in Patients With Secondary Progressive Multiple Sclerosis. Journal of Clinical Neurophysiology. 27(2). 120–125. 11 indexed citations

17.

Argyriou, Andreas A., Charles A. Micchelli, & Massimiliano Pontil. (2009). When Is There a Representer Theorem? Vector Versus Matrix Regularizers. Journal of Machine Learning Research. 10(87). 2507–2529. 67 indexed citations

18.

Argyriou, Andreas A., Mark Herbster, & Massimiliano Pontil. (2005). Combining Graph Laplacians for Semi--Supervised Learning. UCL Discovery (University College London). 18. 67–74. 90 indexed citations

19.

Chroni, Elisabeth, Spiridon Papapetropoulos, Andreas A. Argyriou, & Thodoros Papapetropoulos. (2004). A case of fatal progressive neuropathy. Clinical Neurology and Neurosurgery. 108(1). 45–47. 7 indexed citations

20.

Drousiotou, Anthi, P.A. Ioannou, Georgios Christopoulos, et al.. (1998). Neonatal Screening for Duchenne Muscular Dystrophy: A Novel Semiquantitative Application of the Bioluminescence Test for Creatine Kinase in a Pilot National Program in Cyprus. Genetic Testing. 2(1). 55–60. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact